Certified by Founder Lodge
Novalis Biotech
Belgium - Ghent, Flemish Region
INVESTOR
1 Disclosed Funding Rounds $1,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novalis Biotech is an early stage venture capital fund in life sciences, focusing on enabling technologies in healthcare, such as digital health, diagnostics, genomics and bio-informatics.
| Company | Date | Round | Raised |
|---|---|---|---|
 Alithea Genomics |
May, 24 ,2022 | Seed | $1,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Kubera Health | $6,500,000 | (May 29, 2026)
Solstice | $21,000,000 | (May 29, 2026)
Volt Harbor Inc. | $2,000,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
